Companies
FR
STOXX 600Health Care· Germany

FME

Status-Quo-Player

Fresenius Medical Care

$40.02

-0.79%

Open $39.99·Prev $40.34

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat is vertical integration across the full dialysis value chain, from manufacturing machines and consumables to operating the clinics where those products are used, at a scale no competitor can match.

Published13 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

Company Profile

Fresenius Medical Care AG & Co. KGaA is a Germany-based global leader in dialysis services and products, operating as the world's largest dialysis company. It provides comprehensive dialysis care and related healthcare services to patients with end-stage renal disease (ESRD), treating approximately 300,000 patients across nearly 3,700 clinics worldwide. The company develops and manufactures a broad portfolio of dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, bloodlines, renal pharmaceuticals, and water treatment systems, as well as non-dialysis items like acute cardiopulmonary and apheresis products. Services constitute about three-fourths of its revenue, with the remainder from medical technology products, creating a fully integrated dialysis business that holds roughly 35% of the global dialysis products market. Fresenius Medical Care AG & Co. KGaA supplies its own clinics and other providers, serving critical needs in the healthcare sector focused on renal care and beyond.

Sector

Healthcare

Industry

Medical Care Facilities

Employees

109,916

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.